Copyright Reports & Markets. All rights reserved.

Global Etoricoxib API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Etoricoxib API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Etoricoxib API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Etoricoxib API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Tablet
    • 1.4.3 Others
  • 1.5 Global Etoricoxib API Market Size & Forecast
    • 1.5.1 Global Etoricoxib API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Etoricoxib API Sales Quantity (2018-2029)
    • 1.5.3 Global Etoricoxib API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 HETERO LABS LTD
    • 2.1.1 HETERO LABS LTD Details
    • 2.1.2 HETERO LABS LTD Major Business
    • 2.1.3 HETERO LABS LTD Etoricoxib API Product and Services
    • 2.1.4 HETERO LABS LTD Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 HETERO LABS LTD Recent Developments/Updates
  • 2.2 ALEMBIC PHARMACEUTICALS LTD
    • 2.2.1 ALEMBIC PHARMACEUTICALS LTD Details
    • 2.2.2 ALEMBIC PHARMACEUTICALS LTD Major Business
    • 2.2.3 ALEMBIC PHARMACEUTICALS LTD Etoricoxib API Product and Services
    • 2.2.4 ALEMBIC PHARMACEUTICALS LTD Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 ALEMBIC PHARMACEUTICALS LTD Recent Developments/Updates
  • 2.3 METROCHEM API PRIVATE LTD
    • 2.3.1 METROCHEM API PRIVATE LTD Details
    • 2.3.2 METROCHEM API PRIVATE LTD Major Business
    • 2.3.3 METROCHEM API PRIVATE LTD Etoricoxib API Product and Services
    • 2.3.4 METROCHEM API PRIVATE LTD Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 METROCHEM API PRIVATE LTD Recent Developments/Updates
  • 2.4 Glenmark Life Sciences Limited
    • 2.4.1 Glenmark Life Sciences Limited Details
    • 2.4.2 Glenmark Life Sciences Limited Major Business
    • 2.4.3 Glenmark Life Sciences Limited Etoricoxib API Product and Services
    • 2.4.4 Glenmark Life Sciences Limited Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Glenmark Life Sciences Limited Recent Developments/Updates
  • 2.5 Shandong Langnuo Pharmaceutical
    • 2.5.1 Shandong Langnuo Pharmaceutical Details
    • 2.5.2 Shandong Langnuo Pharmaceutical Major Business
    • 2.5.3 Shandong Langnuo Pharmaceutical Etoricoxib API Product and Services
    • 2.5.4 Shandong Langnuo Pharmaceutical Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Shandong Langnuo Pharmaceutical Recent Developments/Updates
  • 2.6 Sichuan Aoki Pharmaceutical
    • 2.6.1 Sichuan Aoki Pharmaceutical Details
    • 2.6.2 Sichuan Aoki Pharmaceutical Major Business
    • 2.6.3 Sichuan Aoki Pharmaceutical Etoricoxib API Product and Services
    • 2.6.4 Sichuan Aoki Pharmaceutical Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Sichuan Aoki Pharmaceutical Recent Developments/Updates
  • 2.7 Shandong Anxin Pharmaceutical
    • 2.7.1 Shandong Anxin Pharmaceutical Details
    • 2.7.2 Shandong Anxin Pharmaceutical Major Business
    • 2.7.3 Shandong Anxin Pharmaceutical Etoricoxib API Product and Services
    • 2.7.4 Shandong Anxin Pharmaceutical Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Shandong Anxin Pharmaceutical Recent Developments/Updates
  • 2.8 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd.
    • 2.8.1 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Details
    • 2.8.2 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Major Business
    • 2.8.3 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Etoricoxib API Product and Services
    • 2.8.4 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.9 Wuxi Jida Pharmaceutical
    • 2.9.1 Wuxi Jida Pharmaceutical Details
    • 2.9.2 Wuxi Jida Pharmaceutical Major Business
    • 2.9.3 Wuxi Jida Pharmaceutical Etoricoxib API Product and Services
    • 2.9.4 Wuxi Jida Pharmaceutical Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Wuxi Jida Pharmaceutical Recent Developments/Updates
  • 2.10 Chengdu Baiyu Pharmaceutical
    • 2.10.1 Chengdu Baiyu Pharmaceutical Details
    • 2.10.2 Chengdu Baiyu Pharmaceutical Major Business
    • 2.10.3 Chengdu Baiyu Pharmaceutical Etoricoxib API Product and Services
    • 2.10.4 Chengdu Baiyu Pharmaceutical Etoricoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Etoricoxib API by Manufacturer

  • 3.1 Global Etoricoxib API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Etoricoxib API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Etoricoxib API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Etoricoxib API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Etoricoxib API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Etoricoxib API Manufacturer Market Share in 2022
  • 3.5 Etoricoxib API Market: Overall Company Footprint Analysis
    • 3.5.1 Etoricoxib API Market: Region Footprint
    • 3.5.2 Etoricoxib API Market: Company Product Type Footprint
    • 3.5.3 Etoricoxib API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Etoricoxib API Market Size by Region
    • 4.1.1 Global Etoricoxib API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Etoricoxib API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Etoricoxib API Average Price by Region (2018-2029)
  • 4.2 North America Etoricoxib API Consumption Value (2018-2029)
  • 4.3 Europe Etoricoxib API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Etoricoxib API Consumption Value (2018-2029)
  • 4.5 South America Etoricoxib API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Etoricoxib API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Etoricoxib API Sales Quantity by Type (2018-2029)
  • 5.2 Global Etoricoxib API Consumption Value by Type (2018-2029)
  • 5.3 Global Etoricoxib API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Etoricoxib API Sales Quantity by Application (2018-2029)
  • 6.2 Global Etoricoxib API Consumption Value by Application (2018-2029)
  • 6.3 Global Etoricoxib API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Etoricoxib API Sales Quantity by Type (2018-2029)
  • 7.2 North America Etoricoxib API Sales Quantity by Application (2018-2029)
  • 7.3 North America Etoricoxib API Market Size by Country
    • 7.3.1 North America Etoricoxib API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Etoricoxib API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Etoricoxib API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Etoricoxib API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Etoricoxib API Market Size by Country
    • 8.3.1 Europe Etoricoxib API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Etoricoxib API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Etoricoxib API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Etoricoxib API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Etoricoxib API Market Size by Region
    • 9.3.1 Asia-Pacific Etoricoxib API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Etoricoxib API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Etoricoxib API Sales Quantity by Type (2018-2029)
  • 10.2 South America Etoricoxib API Sales Quantity by Application (2018-2029)
  • 10.3 South America Etoricoxib API Market Size by Country
    • 10.3.1 South America Etoricoxib API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Etoricoxib API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Etoricoxib API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Etoricoxib API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Etoricoxib API Market Size by Country
    • 11.3.1 Middle East & Africa Etoricoxib API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Etoricoxib API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Etoricoxib API Market Drivers
  • 12.2 Etoricoxib API Market Restraints
  • 12.3 Etoricoxib API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Etoricoxib API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Etoricoxib API
  • 13.3 Etoricoxib API Production Process
  • 13.4 Etoricoxib API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Etoricoxib API Typical Distributors
  • 14.3 Etoricoxib API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Etoricoxib API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Etoricoxib API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Etoricoxib API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
    Global Etoricoxib API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
    Global Etoricoxib API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
    Global Etoricoxib API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Etoricoxib API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Etoricoxib API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include HETERO LABS LTD, ALEMBIC PHARMACEUTICALS LTD, METROCHEM API PRIVATE LTD, Glenmark Life Sciences Limited and Shandong Langnuo Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Etoricoxib API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥99%
    Purity<99%
    Market segment by Application
    Tablet
    Others
    Major players covered
    HETERO LABS LTD
    ALEMBIC PHARMACEUTICALS LTD
    METROCHEM API PRIVATE LTD
    Glenmark Life Sciences Limited
    Shandong Langnuo Pharmaceutical
    Sichuan Aoki Pharmaceutical
    Shandong Anxin Pharmaceutical
    Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd.
    Wuxi Jida Pharmaceutical
    Chengdu Baiyu Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Etoricoxib API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Etoricoxib API, with price, sales, revenue and global market share of Etoricoxib API from 2018 to 2023.
    Chapter 3, the Etoricoxib API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Etoricoxib API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Etoricoxib API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Etoricoxib API.
    Chapter 14 and 15, to describe Etoricoxib API sales channel, distributors, customers, research findings and conclusion.

    Buy now